{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T09:11:57Z","timestamp":1768727517713,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jviromet.2018.02.004","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T05:57:51Z","timestamp":1518155871000},"page":"8-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Comparison of cobas HCV GT against Versant HCV Genotype 2.0 (LiPA) with confirmation by Sanger sequencing"],"prefix":"10.1016","volume":"255","author":[{"given":"Falah","family":"Yusrina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cui Wen","family":"Chua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun Kiat","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy Si-Yu","family":"Png","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mui Joo","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guan Huei","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedict","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong Kai","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2018.02.004_bib0005","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3892\/ijmm.2012.1209","article-title":"Comparison of three different HCV genotyping methods: core, NS5B sequence analysis and line probe assay","volume":"31","author":"Cai","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jviromet.2018.02.004_bib0010","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3851\/IMP2529","article-title":"A boceprevir failure in a patient infected with HCV genotype 1G: importance and limitations of virus genotyping prior to HCV protease-inhibitor-based therapy","volume":"18","author":"Cento","year":"2013","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jviromet.2018.02.004_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2016.10.009","article-title":"6 HCV genotyping 9G test and its comparison with VERSANT HCV genotype 2.0 assay (LiPA) for the hepatitis C virus genotyping","volume":"239","author":"Chantratita","year":"2017","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2018.02.004_bib0020","doi-asserted-by":"crossref","first-page":"e0153754","DOI":"10.1371\/journal.pone.0153754","article-title":"Using NS5B sequencing for hepatitis C virus genotyping reveals discordances with commercial platforms","volume":"11","author":"Chueca","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jviromet.2018.02.004_bib0025","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa1512610","article-title":"Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection","volume":"373","author":"Feld","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jviromet.2018.02.004_bib0030","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1056\/NEJMoa1402338","article-title":"ABT-450\/r-ombitasvir and dasabuvir with or without ribavirin for HCV","volume":"370","author":"Ferenci","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jviromet.2018.02.004_bib0035","doi-asserted-by":"crossref","first-page":"e0175564","DOI":"10.1371\/journal.pone.0175564","article-title":"The cobas(R) HCV GT is a new tool that accurately identifies Hepatitis C virus genotypes for clinical practice","volume":"12","author":"Fernandez-Caballero","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.jviromet.2018.02.004_bib0040","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/cid\/ciw579","article-title":"Efficacy and safety of sofosbuvir\/velpatasvir in patients with chronic hepatitis C virus infection receiving opioid substitution therapy: analysis of phase 3 ASTRAL trials","volume":"63","author":"Grebely","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jviromet.2018.02.004_bib0045","first-page":"95","article-title":"BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT","volume":"41","author":"Hall","year":"1999","journal-title":"Nucleic Acids Symp. Ser."},{"key":"10.1016\/j.jviromet.2018.02.004_bib0050","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/bioinformatics\/bts199","article-title":"Geneious basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data","volume":"28","author":"Kearse","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jviromet.2018.02.004_bib0055","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","article-title":"Sofosbuvir for previously untreated chronic hepatitis C infection","volume":"368","author":"Lawitz","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jviromet.2018.02.004_bib0060","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jinf.2014.09.008","article-title":"Exploratory trial of ombitasvir and ABT-450\/r with or without ribavirin for HCV genotype 1, 2, and 3 infection","volume":"70","author":"Lawitz","year":"2015","journal-title":"J. Infect."},{"key":"10.1016\/j.jviromet.2018.02.004_bib0065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2016.09.001","article-title":"EASL recommendations on treatment of hepatitis C 2016","volume":"66","author":"European Association for the Study of the Liver","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jviromet.2018.02.004_bib0070","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/hep.27880","article-title":"Direct-acting antiviral drug approvals for treatment of chronic hepatitis C virus infection: scientific and regulatory approaches to clinical trial designs","volume":"62","author":"Mishra","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jviromet.2018.02.004_bib0075","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/hep.27726","article-title":"All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study","volume":"61","author":"Nelson","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jviromet.2018.02.004_bib0080","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1128\/JCM.01960-16","article-title":"Assessment of a novel automatic real-time PCR assay on the cobas 4800 analyzer as a screening platform for hepatitis C virus genotyping in clinical practice: comparison with massive sequencing","volume":"55","author":"Nieto-Aponte","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2018.02.004_bib0085","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","author":"Polaris Observatory HCV Collaborators","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.jviromet.2018.02.004_bib0090","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2147\/CEOR.S106238","article-title":"Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district","volume":"8","author":"Polilli","year":"2016","journal-title":"Clinicoecon. Outcomes Res."},{"key":"10.1016\/j.jviromet.2018.02.004_bib0095","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jviromet.2013.06.002","article-title":"Nucleotide polymorphisms in the 5\u2019-UTR region of HCV can affect the ability of two widely used assays to assign an HCV genotype","volume":"193","author":"Pollicita","year":"2013","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2018.02.004_bib0100","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa1402869","article-title":"ABT-450\/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis","volume":"370","author":"Poordad","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jviromet.2018.02.004_bib0105","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.jcv.2016.08.087","article-title":"Ion torrent next generation sequencing for accurate genotyping and detection of resistance associated variants in HCV and HIV","volume":"82","author":"Rakhmanaliev","year":"2016","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jviromet.2018.02.004_bib0110","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jviromet.2018.02.004_bib0115","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1515\/cclm-2016-0620","article-title":"Evaluation of the new cobas(R) HCV genotyping test based on real-time pcrs of three different HCV genome regions","volume":"55","author":"Stelzl","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jviromet.2018.02.004_bib0120","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1306218","article-title":"Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection","volume":"370","author":"Sulkowski","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jviromet.2018.02.004_bib0125","doi-asserted-by":"crossref","first-page":"e0126764","DOI":"10.1371\/journal.pone.0126764","article-title":"Genotypic distribution of hepatitis C virus in Thailand and Southeast Asia","volume":"10","author":"Wasitthankasem","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.jviromet.2018.02.004_bib0130","series-title":"Guidelines for the Screening, Care and Treatment of Persons With Chronic Hepatitis C Infection","author":"WHO Guidelines","year":"2016"},{"key":"10.1016\/j.jviromet.2018.02.004_bib0135","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/jmv.21287","article-title":"Complete genome sequencing and phylogenetic analysis of HCV isolates from China reveals a new subtype, designated 6u","volume":"80","author":"Xia","year":"2008","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jviromet.2018.02.004_bib0140","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1128\/JCM.00882-14","article-title":"Performance comparison of the Versant HCV Genotype 2.0 assay (LiPA) and the Abbott Realtime HCV Genotype II assay for detecting hepatitis C virus Genotype 6","volume":"52","author":"Yang","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2018.02.004_bib0145","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.7754\/Clin.Lab.2016.151210","article-title":"Emergence of hepatitis C virus genotype recombinant forms 2k\/1b in Georgia","volume":"62","author":"Zakalashvili","year":"2016","journal-title":"Clin. Lab."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093417305943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093417305943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T10:50:05Z","timestamp":1759056605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093417305943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":29,"alternative-id":["S0166093417305943"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2018.02.004","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of cobas HCV GT against Versant HCV Genotype 2.0 (LiPA) with confirmation by Sanger sequencing","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2018.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}